The ARUP Consult Editorial Board, made up of University of Utah Department of Pathology faculty and residents, helps lead innovative and ongoing improvements to ARUP Consult. Members work with the ARUP Consult editorial team to establish development goals, set priorities, and periodically review and update the Consult Editorial Policy.
Dr. Jackson directs activities of the Informatics Department at ARUP, including ARUP Consult, decision support, test utilization management, and software product management. He received his BA in mathematics, his MS in medical informatics, and his MD from the University of Utah. He completed a clinical pathology residency at Dartmouth-Hitchcock Medical Center. Before joining ARUP, Dr. Jackson was a staff clinical pathologist and informaticist at Dartmouth-Hitchcock Medical Center, a product manager for a Belgium-based medical software firm, and a National Library of Medicine informatics fellow at the University of Utah.
Dr. Jackson’s research interests include economic analysis of diagnostic testing, physician utilization of laboratory tests, and corporate social responsibility in healthcare. He is certified in clinical pathology by the American Board of Pathology.
Hannah Anderson is a genetic counselor at ARUP Laboratories, specializing in genetics, cytogenetics, and fluorescence in situ hybridization (FISH)—oncology, prenatal aneuploidy screening, microarray, and noninvasive prenatal testing. She received her master’s degree in medical and molecular genetics from the Indiana University School of Medicine and is certified by the American Board of Genetic Counseling. Her research interests include carrier screening and next generation sequencing in the prenatal setting.
Dr. Ji received her PhD in molecular pharmacology and experimental therapeutics at the Mayo Clinic in Rochester, Minnesota.
She is board certified in clinical pharmacology and clinical molecular genetics, and she currently serves as codirector of the Laboratory Genetics and Genomics fellowship program at the University of Utah School of Medicine. Dr. Ji’s primary clinical and research focus is pharmacogenomics, and she has coauthored several instrumental clinical guidelines for clinical pharmacogenomics testing and implementation. Dr. Ji has also endeavored to develop a valued-added model for noninvasive prenatal testing from a reference laboratory perspective as the medical director of the test at ARUP.
Dr. Johnson-Davis received her BS in biochemistry from the University of California, Riverside, and her PhD in pharmacology from the University of Utah. She served as a postdoctoral research associate at the Center for Human Toxicology and completed a postdoctoral fellowship in clinical chemistry in the University of Utah School of Medicine Department of Pathology.
Dr. Johnson-Davis is board certified in clinical chemistry and toxicologic chemistry. She is a diplomate of the American Board of Clinical Chemistry and a fellow of the American Association for Clinical Chemistry (AACC) Academy. Dr. Johnson-Davis currently serves as the director for the Clinical Chemistry fellowship program in the Department of Pathology at the University of Utah.
Dr. Kim is a medical director of molecular oncology at ARUP Laboratories and an assistant professor of clinical pathology in the University of Utah Department of Pathology. He specializes in molecular oncology in solid tumors. He completed his medical degree at the University of South Alabama College of Medicine. He then completed an orthopedic surgery residency at the Medical University of South Carolina, followed by an anatomic and clinical pathology residency at the University of Florida College of Medicine. He also received his master’s degree in biomedical informatics at the University of Florida College of Medicine. Following that, Dr. Kim finished a fellowship in molecular genetic pathology at Cedars-Sinai Medical Center.
Dr. Kim is board certified in anatomic and clinical pathology and molecular genetics pathology. He is a member of the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the College of American Pathologists. His research interests include oncologic genomics by next generation sequencing and biomedical informatics.
Dr. Slev earned her PhD in immunology and laboratory medicine from the University of Florida, Gainesville, and completed a fellowship in clinical chemistry at the University of Utah.
Her research interests are in immunogenetics and pathogen interactions, particularly HIV and viral hepatitis.
Dr. Straseski received her PhD in pathology and laboratory medicine from the University of Wisconsin-Madison and completed a postdoctoral fellowship in clinical chemistry at the Johns Hopkins Medical Institutions in Baltimore, Maryland. She also holds a master’s degree in bacteriology and immunology and a bachelor of science degree in medical technology from the University of Wisconsin-Madison. She is an active member of the AACC and the American Society for Clinical Pathology and serves as the chair of the Board of Editors for Clinical Laboratory News.
Dr. Straseski’s research interests are reproductive endocrinology, specifically, markers of ovarian reserve and fertility.